Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

Use of the elevated plus maze in the search for novel anxiolytic agents

Article Abstract:

Research on new anxiolytic agents and the psychological and neurochemical bases of anxiety has made extensive use of the rodent model of anxiety known as the elevated plus maze test. The test's popularity can be attributed to its speed and simplicity, its cheap equipment and its ability to detect putative anxiolytics such as CCKB receptor antagonists. However, the test's proneness' for false positives and false negatives makes it unsuitable for anxiolytic and anxiety research.

Author: Dawson, Gerard R., Tricklebank, Mark D.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1995
Models, Usage, Tranquilizing drugs, Tranquilizing agents, Mandatory drug testing, Drug testing, Anxiety

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Two novel families of ectonucleotidases: molecular structures, catalytic properties and a search for function

Article Abstract:

The E-NTPase and PDNPase are two novel and unrelated ectonucleotidase families that have wide substrate specificity, as well as tissue and cell distribution. Members of the E-NTPase family hydrolyse either nucleoside 5'-triphosphates or both diphosphates and nucleoside 5'-triphosphates. Members of the PDNPase family, on the other hand, hydrolyse pyrophosphate bonds of nucleotides and nucleotide sugars and phosphodiester bonds of nucleotides and nucleic acids.

Author: Zimmermann, Herbert
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1999
Analysis, Nucleotide sequence, Base sequence, Nucleotides

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Beta-secretase revealed: starting gate for race to novel therapies for Alzheimer's disease

Article Abstract:

Four teams of researchers have independently succeeded in isolating beta-secretase. This enzyme breaks down the amyloid precursor protein to form beta-amyloid. Beta amyloid can accumulate in the brain, damaging brain cells and possibly causing Alzheimer's dementia.

Author: Skovronsky, Daniel M., Lee, Virginia M.-Y.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 2000
Alzheimer's disease, Proteases, Identification and classification, Amyloid beta-protein

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research
Similar abstracts:
  • Abstracts: G protein regulation of adenylate cyclase. Receptor sites for Ca2+ channel antagonists. Direct regulation of cardiac Ca2+ channels by G proteins: neither proven nor necessary?
  • Abstracts: Receptor-gated ion channels may be selective CNS targets for ethanol. part 2 Endogenous bacterial receptors should cause anxiety
  • Abstracts: Drugs of abuse: behavioral principles, methods and terms. Peripheral versus central mechanisms in the behavioral effects of cytokines
  • Abstracts: Anthranoid laxatives and colorectal cancer. Nucleoside diphosphate kinases as potential new targets for control of development and cancer
  • Abstracts: Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability. In vivo studies with antisense oligonucleotides
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.